Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 633

1.

PARKIN Inactivation Links Parkinson's Disease to Melanoma.

Hu HH, Kannengiesser C, Lesage S, André J, Mourah S, Michel L, Descamps V, Basset-Seguin N, Bagot M, Bensussan A, Lebbé C, Deschamps L, Saiag P, Leccia MT, Bressac-de-Paillerets B, Tsalamlal A, Kumar R, Klebe S, Grandchamp B, Andrieu-Abadie N, Thomas L, Brice A, Dumaz N, Soufir N.

J Natl Cancer Inst. 2015 Dec 17;108(3). pii: djv340. doi: 10.1093/jnci/djv340. Print 2016 Mar.

PMID:
26683220
2.

Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin.

Siddiqui A, Bhaumik D, Chinta SJ, Rane A, Rajagopalan S, Lieu CA, Lithgow GJ, Andersen JK.

J Neurosci. 2015 Sep 16;35(37):12833-44. doi: 10.1523/JNEUROSCI.0109-15.2015.

3.

Dysregulation of Parkin-mediated mitophagy in thyroid Hürthle cell tumors.

Lee J, Ham S, Lee MH, Kim SJ, Park JH, Lee SE, Chang JY, Joung KH, Kim TY, Kim JM, Sul HJ, Kweon GR, Jo YS, Kim KS, Shong YK, Gasparre G, Chung JK, Porcelli AM, Shong M.

Carcinogenesis. 2015 Nov;36(11):1407-18. doi: 10.1093/carcin/bgv122. Epub 2015 Sep 8.

PMID:
26354775
4.

A Ubl/ubiquitin switch in the activation of Parkin.

Sauvé V, Lilov A, Seirafi M, Vranas M, Rasool S, Kozlov G, Sprules T, Wang J, Trempe JF, Gehring K.

EMBO J. 2015 Oct 14;34(20):2492-505. doi: 10.15252/embj.201592237. Epub 2015 Aug 7.

5.

Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.

Guo JF, Dong XL, Xu Q, Li N, Yan XX, Xia K, Tang BS.

Neurosci Lett. 2015 Sep 14;604:47-51. doi: 10.1016/j.neulet.2015.07.046. Epub 2015 Aug 1.

PMID:
26240990
6.

Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.

Kazlauskaite A, Martínez-Torres RJ, Wilkie S, Kumar A, Peltier J, Gonzalez A, Johnson C, Zhang J, Hope AG, Peggie M, Trost M, van Aalten DM, Alessi DR, Prescott AR, Knebel A, Walden H, Muqit MM.

EMBO Rep. 2015 Aug;16(8):939-54. doi: 10.15252/embr.201540352. Epub 2015 Jun 25.

7.

Evaluation of PARKIN gene variants in West Bengal Parkinson's disease patients.

Sanyal J, Jana A, Ghosh E, Banerjee TK, Chakraborty DP, Rao VR.

J Hum Genet. 2015 Sep;60(9):485-92. doi: 10.1038/jhg.2015.49. Epub 2015 May 28.

PMID:
26016408
8.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Tijero B, Gabilondo I, Lezcano E, Teran-Villagrá N, Llorens V, Ruiz-Martinez J, Marti-Masso JF, Carmona M, Luquin MR, Berganzo K, Fernandez I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 Jul;21(7):717-22. doi: 10.1016/j.parkreldis.2015.04.012. Epub 2015 Apr 23.

PMID:
25960264
9.

Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Fiesel FC, Caulfield TR, Moussaud-Lamodière EL, Ogaki K, Dourado DF, Flores SC, Ross OA, Springer W.

Hum Mutat. 2015 Aug;36(8):774-86. doi: 10.1002/humu.22808. Epub 2015 Jun 3.

PMID:
25939424
10.

The KM-parkin-DB: A Sub-set MutationView Database Specialized for PARK2 (PARKIN) Variants.

Mitsuyama S, Ohtsubo M, Minoshima S, Shimizu N.

Hum Mutat. 2015 Aug;36(8):E2430-40. doi: 10.1002/humu.22803. Epub 2015 Jun 3.

PMID:
25907632
11.

Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches.

Ozgul S, Kasap M, Akpinar G, Kanli A, Güzel N, Karaosmanoglu K, Baykal AT, Iseri P.

Neurochem Int. 2015 Jun-Jul;85-86:1-13. doi: 10.1016/j.neuint.2015.03.007. Epub 2015 Apr 9.

PMID:
25865804
12.

Linking microtubules to Parkinson's disease: the case of parkin.

Cappelletti G, Casagrande F, Calogero A, De Gregorio C, Pezzoli G, Cartelli D.

Biochem Soc Trans. 2015 Apr;43(2):292-6. doi: 10.1042/BST20150007. Review.

PMID:
25849932
13.

Genomic instability in the PARK2 locus is associated with Parkinson's disease.

Ambroziak W, Koziorowski D, Duszyc K, Górka-Skoczylas P, Potulska-Chromik A, Sławek J, Hoffman-Zacharska D.

J Appl Genet. 2015 Nov;56(4):451-61. doi: 10.1007/s13353-015-0282-9. Epub 2015 Apr 2.

14.

A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Cornejo-Olivas MR, Torres L, Mata IF, Mazzetti P, Rivas D, Cosentino C, Inca-Martinez M, Cuba JM, Zabetian CP, Leverenz JB.

Parkinsonism Relat Disord. 2015 May;21(5):444-8. doi: 10.1016/j.parkreldis.2015.01.005. Epub 2015 Jan 15.

15.

REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations.

Sixel-Döring F, Lohmann K, Klein C, Trenkwalder C, Mollenhauer B.

Mov Disord. 2015 Apr;30(4):597-8. doi: 10.1002/mds.26193. Epub 2015 Mar 15. No abstract available.

PMID:
25771888
16.

Parkin structure and function.

Seirafi M, Kozlov G, Gehring K.

FEBS J. 2015 Jun;282(11):2076-88. doi: 10.1111/febs.13249. Epub 2015 Mar 16. Review.

17.

Chemogenomic profiling of endogenous PARK2 expression using a genome-edited coincidence reporter.

Hasson SA, Fogel AI, Wang C, MacArthur R, Guha R, Heman-Ackah S, Martin S, Youle RJ, Inglese J.

ACS Chem Biol. 2015 May 15;10(5):1188-97. doi: 10.1021/cb5010417. Epub 2015 Feb 26.

PMID:
25689131
18.

Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains.

Ye X, Sun X, Starovoytov V, Cai Q.

Hum Mol Genet. 2015 May 15;24(10):2938-51. doi: 10.1093/hmg/ddv056. Epub 2015 Feb 12.

19.

Expression pattern of parkin isoforms in lung adenocarcinomas.

D'Amico AG, Maugeri G, Magro G, Salvatorelli L, Drago F, D'Agata V.

Tumour Biol. 2015 Jul;36(7):5133-41. doi: 10.1007/s13277-015-3166-z. Epub 2015 Feb 6.

PMID:
25656612
20.

A recurrent mutation in PARK2 is associated with familial lung cancer.

Xiong D, Wang Y, Kupert E, Simpson C, Pinney SM, Gaba CR, Mandal D, Schwartz AG, Yang P, de Andrade M, Pikielny C, Byun J, Li Y, Stambolian D, Spitz MR, Liu Y, Amos CI, Bailey-Wilson JE, Anderson M, You M.

Am J Hum Genet. 2015 Feb 5;96(2):301-8. doi: 10.1016/j.ajhg.2014.12.016. Epub 2015 Jan 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk